BPXXY Financial Statements & Analysis
Complete financial statements for BPXXY including income statement, balance sheet, and cash flow statement. Analyze BPXXY's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
9.4% ↑
Net Income
24.5% ↑
Gross Margin
6.4% ↑
Operating Margin
16.3% ↑
Balance Sheet
Current Ratio
-12.2% ↓
Debt to Equity
-50.7% ↑
Asset Turnover
-24.8% ↓
Cash Flow
Operating Cash Flow
447.0% ↑
Net Cash Flow
272.6% ↑
Free Cash Flow
400.5% ↑
Cash Flow to Debt
577.4% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 7.63B | 8.35B | 9.4% | |
| Gross Profit | 5.99B | 6.97B | 16.5% | |
| Operating Income | 2.05B | 2.62B | 27.3% | |
| Net Income | 1.40B | 1.75B | 24.5% | |
| EPS | 1.98 | 1.78 | 10.1% | |
| EBITDA | 2.42B | 3.12B | 29.1% | |
| Gross Margin | 78.54% | 83.56% | 6.4% | |
| Operating Margin | 26.94% | 31.34% | 16.3% | |
| Net Income Margin | 18.40% | 20.93% | 13.8% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 8.35B | 7.63B | 7.39B | — | — |
| Gross Profit | 6.97B | 5.99B | 5.88B | — | — |
| Operating Income | 2.62B | 2.05B | 1.72B | — | — |
| Net Income | 1.75B | 1.40B | 1.52B | — | — |
| EPS | 1.78 | 1.98 | 2.14 | — | — |
| EBITDA | 3.12B | 2.42B | 2.04B | — | — |
| Gross Margin | 83.56% | 78.54% | 79.54% | — | — |
| Operating Margin | 31.34% | 26.94% | 23.35% | — | — |
| Net Income Margin | 20.93% | 18.40% | 20.57% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into BPXXY's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics